首页> 美国卫生研究院文献>other >Development and validation of a risk model for identification of non-neutropenic critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
【2h】

Development and validation of a risk model for identification of non-neutropenic critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.

机译:开发和验证标识的非中性粒细胞减少危重成人患者的侵袭性念珠菌感染的高危风险模型:真菌感染风险评估(FIRE)研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDThere is increasing evidence that invasive fungal disease (IFD) is more likely to occur in non-neutropenic patients in critical care units. A number of randomised controlled trials (RCTs) have evaluated antifungal prophylaxis in non-neutropenic, critically ill patients, demonstrating a reduction in the risk of proven IFD and suggesting a reduction in mortality. It is necessary to establish a method to identify and target antifungal prophylaxis at those patients at highest risk of IFD, who stand to benefit most from any antifungal prophylaxis strategy.
机译:背景技术越来越多的证据表明,在重症监护病房的非中性粒细胞减少患者中,侵袭性真菌病(IFD)的发生可能性更高。许多随机对照试验(RCT)评估了非中性粒细胞减少症,重症患者的抗真菌药物预防效果,证明已证实的IFD风险降低,并提示死亡率降低。有必要建立一种方法来识别和预防那些有IFD最高风险的患者,这些患者将从任何抗真菌预防策略中受益最大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号